Senior insider sale
SVP, Head of Res./Clin. Dev. at ABEONA THERAPEUTICS INC. — senior position signals high conviction
$503.7K
99.82K shares
What this filing means
SESHADRI VISHWAS plans to sell 99.82K shares of ABEONA THERAPEUTICS INC. valued at approximately $503.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/31/2026ACC: 0001972481-26-000122
Officer· SVP, Head of Res./Clin. Dev.
Since Jun 2021
99.82K
Shares to sell
$503.7K
Approx. market value
29.98K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Equity Compensation
6/5/2024
29.98KTotal acquired29.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/5/2024 | Restricted Stock Equity Compensation | 29.98K | — |
| Total | 29.98K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
69.83K
Market value
$372.3K
1/22/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
29.98K
Market value
$131.5K
3/31/2026
Total
Units
99.82K
Value
$503.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/22/2026 | 69.83K | $372.3K | — | Completed |
| Planned — Approximate Date | ||||
3/31/2026 | 29.98K | $131.5K | Nasdaq | Planned |
| Total | 99.82K | $503.7K | ||